Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms

Regulatory Peptides

Volumn 179, Issue 1-3, 2012, Pages 50-54

  Kadoglou, Nikolaos P E ^a   Papadakis, Ioannis ^a   Moulakakis, Konstantinos G ^b   Ikonomidis, Ignatios ^a   Alepaki, Maria ^b   Moustardas, Petros ^b   Lampropoulos, Stylianos ^c   Karakitsos, Petros ^b   Lekakis, John ^a   Liapis, Christos D ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Department of Cardiology   (Greece)

Author keywords

Abdominal aortic aneurysm; Arterial stiffness; Osteopontin; Osteoprotegerin; Pulse wave velocity

Indexed keywords

BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; OSTEOPONTIN; OSTEOPROTEGERIN;

ABDOMINAL AORTA ANEURYSM; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DOWN REGULATION; DRUG USE; ENDOVASCULAR SURGERY; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULSE WAVE; SMOKING; UNIVARIATE ANALYSIS;

AGED; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; OSTEOPONTIN; OSTEOPROTEGERIN; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84866558382     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.08.014     Document Type: Article

References (36)

1. Mitchell G.F., Hwang S.J., Vasan R.S., Larson M.G., Pencina M.J., Hamburg N.M., Vita J.A., Levy D., Benjamin E.J. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121:505-511.
2. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 55:1318-1327.
3. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24:1161-1170.
4. Farrar D.J., Bond M.G., Riley W.A., Sawyer J.K. Anatomic correlated of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 1991, 83:1754-1763.
5. Vik A., Mathiesen E.B., Brox J., Wilsgaard T., Njølstad I., Jørgensen L., Hansen J.B. Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. J Thromb Haemost 2011, 9:638-644.
6. Moran C.S., McCann M., Karan M., Norman P., Ketheesan N., Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 2005, 111:3119-3125.
7. Blázquez-Medela A.M., García-Ortiz L., Gómez-Marcos M.A., Recio-Rodriguez J.I., Sánchez-Rodríguez A., López-Novoa J.M., Martínez-Salgado C. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. Eur J Clin Invest 2012, 42:548-556.
8. Waller A.H., Sanchez-Ross M., Kaluski E., Klapholz M. Osteopontin in cardiovascular disease: a potential therapeutic target. Cardiol Rev 2010, 18:125-131.
9. Singh M., Foster C.R., Dalal S., Singh K. Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI. J Mol Cell Cardiol 2010, 48:538-543.
10. Golledge J., Muller J., Shephard N., Clancy P., Smallwood L., Moran C., Dear A.E., Palmer L.J., Norman P.E. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2007, 27:655-660.
11. Dawson J., Cockerill G.W., Choke E., Belli A.M., Loftus I., Thompson M.M. Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg 2007, 45:350-356.
12. Ikonomidis I., Stamatelopoulos K., Lekakis J., Vamvakou G.D., Kremastinos D.T. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008, 199:3-11.
13. Triantafyllidi H., Tzortzis S., Lekakis J., Ikonomidis I., Arvaniti C., Trivilou P., Kontsas K., Siafakas N., Zerva L., Stamboulis E., Kremastinos D., Anastasiou-Nana M. Association of target organ damage with three arterial stiffness indexes according to blood pressure dipping status in untreated hypertensive patients. Am J Hypertens 2010, 23:1265-1272.
14. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., Pannier B., Vlachopoulos C., Wilkinson I., Struijker-Boudier H. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
15. Lantelme P., Dzudie A., Milon H., Bricca G., Legedz L., Chevalier J.M., Feugier P. Effect of abdominal aortic grafts on aortic stiffness and central hemodynamics. J Hypertens 2009, 27:1268-1276.
16. Dobson G., Flewitt J., Tyberg J.V., Moore R., Karamanoglu M. Endografting of the descending thoracic aorta increases ascending aortic input impedance and attenuates pressure transmission in dogs. Eur J Vasc Endovasc Surg 2006, 32:129-135.
17. Luo J., Fujikura K., Tyrie L.S., Tilson M.D., Konofagou E.E. Pulse wave imaging of normal and aneurysmal abdominal aortas in vivo. IEEE Trans Med Imaging 2009, 28:477-486.
18. Latham R.D., Westerhof N., Sipkema P., Rubal B.J., Reuderink P., Murgo J.P. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation 1985, 72:1257-1269.
19. Laurent S., Boutouyrie P., Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005, 45:1050-1055.
20. Russo L. Thoracic aortic compliance as a determinant of rupture of abdominal aortic aneurysms. Ann N Y Acad Sci 2006, 1085:363-366.
21. Rentschler M.E., Baxter B.T. Screening aortic drug treatments through arterial compliance measurements. Curr Vasc Pharmacol 2008, 6:250-257.
22. Sung S.H., Yu W.C., Cheng H.M., Chuang S.Y., Wang K.L., Huang C.M., Chen C.H. Pulsatile hemodynamics and clinical outcomes in acute heart failure. Am J Hypertens 2011, 24:775-782.
23. Kadoglou N.P., Gerasimidis T., Golemati S., Kapelouzou A., Karayannacos P.E., Liapis C.D. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. J Vasc Surg 2008, 47:55-62.
24. Moran C.S., Clancy P., Biros E., Blanco-Martin B., McCaskie P., Palmer L.J., Coomans D., Norman P.E., Golledge J. Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. Clin Endocrinol (Oxf) 2010, 72:128-132.
25. Zagura M., Serg M., Kampus P., Zilmer M., Zilmer K., Eha J., Unt E., Lieberg J., Kals J. Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. Am J Hypertens 2010, 23:586-591.
26. Kim S.M., Lee J., Ryu O.H., Lee K.W., Kim H.Y., Seo J.A., Kim S.G., Kim N.H., Baik S.H., Choi D.S., Choi K.M. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol 2005, 63:594-598.
27. Schultz G., Tedesco M.M., Sho E., Nishimura T., Sharif S., Du X., Myles T., Morser J., Dalman R.L., Leung L.L. Enhanced abdominal aortic aneurysm formation in thrombin-activatable procarboxypeptidase B-deficient mice. Arterioscler Thromb Vasc Biol 2010, 30:1363-1370.
28. Zheng Y.H., Tian C., Meng Y., Qin Y.W., Du Y.H., Du J., Li H.H. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J Cell Physiol 2012, 227:127-135.
29. Mi T., Nie B., Zhang C., Zhou H. The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication. J Huazhong Univ Sci Technolog Med Sci 2011, 31:602-607.
30. Bazzichi L., Ghiadoni L., Rossi A., Bernardini M., Lanza M., De Feo F., Giacomelli C., Mencaroni I., Raimo K., Rossi M., Mazzone A.M., Taddei S., Bombardieri S. Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis. Mol Med 2009, 15:402-406.
31. Barreto D.V., Lenglet A., Liabeuf S., Kretschmer A., Barreto F.C., Nollet A., Slama M., Choukroun G., Brazier M., Massy Z. Prognostic implication of plasma osteopontin levels in patients with chronic kidney disease. Nephron Clin Pract 2011, 117:c363-c372.
32. Middleton R.K., Lloyd G.M., Bown M.J., Cooper N.J., London N.J., Sayers R.D. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg 2007, 45:574-580.
33. Vucevic D, Maravic-Stojkovic V, Vasilijic S, Borovic-Labudovic M, Majstorovic I, Radak D, Jevtic M, Milosavljevic P, Colic M. Inverse production of IL-6 and IL-10 by abdominal aortic aneurysm explant tissues in culture. Cardiovasc Pathol. (in press).
34. Wallinder J., Bergqvist D., Henriksson A.E. Proinflammatory and anti-inflammatory cytokine balance in patients with abdominal aortic aneurysm and the impact of aneurysm size. Vasc Endovascular Surg 2009, 43:258-261.
35. Hallow K.M., Taylor W.R., Rachev A., Vito R.P. Markers of inflammation collocate with increased wall stress in human coronary arterial plaque. Biomech Model Mechanobiol. 2009, 8:473-486.
36. Kadoglou N.P., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., Liapis C.D. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J Vasc Surg 2010, 51:114-121.